GB Patent

GB2036048A — Polymer compounds, process for their preparation and arteriosclerosis treating agents containing them

Assigned to Mitsubishi Chemical Corp · Expires 1980-06-25 · 46y expired

What this patent protects

A crosslinked polymer is obtained from ammonia, ethylenediamine or a polyethylenepolyamine having a degree of repeating unit of 2-1500, and a bifunctional compound of the formula: Y-M-Z wherein Y is a -CH2X group (wherein X represents a chlorine, bromine or iodine atom) or a …

USPTO Abstract

A crosslinked polymer is obtained from ammonia, ethylenediamine or a polyethylenepolyamine having a degree of repeating unit of 2-1500, and a bifunctional compound of the formula: Y-M-Z wherein Y is a -CH2X group (wherein X represents a chlorine, bromine or iodine atom) or a <IMAGE> group, M is a single bond, a -(CH2)m- group (wherein M represents 1, 2 or 3), a -CH2-O-CH2-group or a -CH2-O-(CH2)k-O-CH2 group (wherein k represents 1,2,3 or 4), and Z is a -CH(OH)-CH2X group (wherein X is the same as hereinbefore defined) or a <IMAGE> group, and 20 percent or more of the nitrogen atoms thereof are combined with lower alkyl groups to form a quaternary ammonium salt. An arteriosclerosis treating agent containing the compound as an active ingredient and a process for preparing the compound are also disclosed.

Drugs covered by this patent

Patent Metadata

Patent number
GB2036048A
Jurisdiction
GB
Classification
Expires
1980-06-25
Drug substance claim
No
Drug product claim
No
Assignee
Mitsubishi Chemical Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.